Labshake search
Citations for R&D Systems :
801 - 850 of 3738 citations for 1 2 Bromoethoxy 3 5 dimethylbenzene 97+% since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2023Quote: ... cells were treated with Idasanutlin (5 μM; R&D Systems, #12-35-22-07) or Doxorubicin (0.5 µM ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5) 10 ng/ml TGFβ1 (766-MB-005, R&D systems, Minneapolis, MN, US), 6 ...
-
bioRxiv - Molecular Biology 2024Quote: The FKBP12F36V-NPM1-ESCs were treated with dTAG-13 (R&D Systems, 6605/5) at 100nM for 3 days and DMSO was used as a control ...
-
bioRxiv - Microbiology 2024Quote: ... supplemented with 5% fetal bovine serum (FBS; R&D systems, Flower Branch, GA, USA) and 1% antibiotic-antimycotic solution (Gibco ...
-
bioRxiv - Neuroscience 2024Quote: ... or 5 µg/mL of a recombinant human efnB2-Fc (R&D Systems, U.S.A.). Both recombinant proteins were pre-clustered with 10 µg/mL of an anti-human IgG antibody (Thermo Fisher ...
-
bioRxiv - Microbiology 2024Quote: ... supplemented with 5% fetal bovine serum (FBS; R&D systems, Flower Branch, GA, USA) and a 1% antibiotic-antimycotic solution (Gibco ...
-
bioRxiv - Molecular Biology 2020Quote: ... Mycoplasma testing was performed every 3 months with the MycoProbe mycoplasma detection kit from R&D systems (Minneapolis, MN). None of the cell lines used in this study are found on the misidentified cell lines list from the International Cell Line Authentication Committee.
-
bioRxiv - Cancer Biology 2021Quote: ... Negative control cells were produced by treatment with 10 μM Z-DEVD-FMK caspase-3 inhibitor (R&D systems). 200μl of cell suspension from each cell line including the negative control group was transferred into a flow cytometry tube before being treated with 2.5μl of 0.2mM NucViewTM 488 caspase-3 substrate (fluorogenic DNA dye and DEVD moiety substrate for caspase-3 ...
-
bioRxiv - Developmental Biology 2022Quote: ... 0.03 to 3 μg/well of the soluble mouse or human HA-tagged recombinant fibulin 7 (R&D Systems) in 2% dry milk/TBS and 2 mM CaCl2 were added to the wells and incubated for 3 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... All cell lines were tested for Mycoplasma routinely every 3 months using MycoProbe Mycoplasma Detection Kit (R&D Systems).
-
bioRxiv - Microbiology 2023Quote: ... coli were made from an overnight agar culture and incubated with 3 μM HMGB1 recombinant protein (R&D systems) reconstituted in 1mM DTT ...
-
bioRxiv - Immunology 2024Quote: ... and Cl13-infected mice was measured by Mouse/Rat Flt-3 Ligand/FLT3L Quantikine ELISA Kit (R&D Systems), following the manufacturer’s instructions ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant human IL-2 protein was purchased from R&D Systems (Minneapolis, MN). Recombinant mouse Flt3 ligand (Flt3L ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 20 IU/mL rhIL-2 (R&D Systems Cat# 202-IL) for 72±4 hours at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human IL-2 protein was purchased from R&D Systems (Minneapolis, MN). Recombinant mouse Flt3 ligand (Flt3L ...
-
bioRxiv - Bioengineering 2020Quote: ... 300 μl of reagent diluent (Reagent diluent concentrate 2, DY995, R&D systems) was added and incubated for an hour to block the coated plate ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems, Minneapolis, MN).
-
bioRxiv - Immunology 2020Quote: ... and an Equine IL-2 DuoSet ELISA (R&D Systems, Minneapolis, MN, USA). Measurements were performed in duplicate according to the manufacturer’s protocol.
-
bioRxiv - Immunology 2020Quote: ... anti-human IL-37 (2 μg/ml, goat polyclonal, R&D Systems, AF1975), anti-human caspase-1 p20 (1:1000 ...
-
bioRxiv - Immunology 2022Quote: ... alone or with mouse recombinant IL-2 (R&D Systems, 50 ng/ml) for 15 minutes at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL FGF-2 (R&D Systems, 233-FB-010), and 20 ng/mL PDGF-AA (R&D Systems ...
-
bioRxiv - Microbiology 2022Quote: ... AF488 anti-SARS-CoV-2 Spike S1 Subunit (R&D Systems,Cat# FAB105403G), FITC anti-Influenza A NP (Thermofisher ...
-
bioRxiv - Immunology 2024Quote: ... Intraperitoneal injections of 2.5μg/0.02kg rhIL-15 (R&D systems; Supplemental Table 2) were performed for 3 weeks to increase reconstitution and maturation of human NK cells in hBLT mice ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Microbiology 2023Quote: ... were coated with 100 µl rSARS-CoV-2 spike protein (R&D Systems). To detect total IgA+-expressing B cells ...
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Immunology 2023Quote: ... probed with anti-mouse Ms-RD-SARS-COV-2 (R&D Systems, MAB105401) followed by HRP secondary antibody provided in Jess kits (Protein Simple ...
-
bioRxiv - Immunology 2023Quote: ... and the Mouse/Rat Angiopoietin-2 Quantikine ELISA Kit (MANG20, R&D Systems), respectively ...
-
bioRxiv - Immunology 2023Quote: Recombinant Human IL-2 and human TGF-β were from R&D systems. Anti-mouse CD3 and biotin-anti-CD3 (145-2C11 ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-2 (R&D systems, 404-ML-010)) ...
-
bioRxiv - Cancer Biology 2024Quote: ... recombinant mouse lipocalin-2 (R&D Systems, #1857-LC-50, 100 ng/ml), liproxstatin-1 (Selleck Chemicals ...
-
bioRxiv - Physiology 2024Quote: ... and anti-mouse integrin-α7-A700 (R&D Systems, cf. Supplemental Table 2). Gating strategy for MuSC isolation using cell surface markers was as followed ...
-
bioRxiv - Microbiology 2024Quote: ... 2) 50 nM recombinant USP2 catalytic domain (R&D systems, Cat# E-504), 3 ...
-
bioRxiv - Immunology 2024Quote: ... ELISA was performed using the mouse Lipocalin-2 DuoSet kit (R&D Systems) as per manufacturer’s instructions ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human IFN-γ (2 ng/ml) (285-IF-100, R&D Systems), recombinant human TNFα (10 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 ng/mL glial cell line-derived neurotrophic factor (GDNF) (R&D Systems, Minneapolis ...
-
Langerhans cells regulate immunity in adulthood by regulating postnatal dermal lymphatic developmentbioRxiv - Immunology 2024Quote: ... recombinant PIGF-2 (0.5 μg/each ear, R&D systems, # 465-PL-050), and recombinant VEGF-C (0.5 μg/each ear ...
-
bioRxiv - Neuroscience 2024Quote: ... and triggering receptor expressed on myeloid cells 2 (TREM2) (R&D Systems, #AF1729), was performed as described in Table 1 ...
-
bioRxiv - Cell Biology 2024Quote: ... coated O/N at 4°C with 2% BME® (R&D systems) or 5 µg/ml recombinant Invasin protein ...
-
bioRxiv - Cancer Biology 2024Quote: ... Lipocalin-2 was measured using the DuoSetTM ELISA development system (R&D systems) according to manufacturer’s instructions ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).
-
bioRxiv - Molecular Biology 2020Quote: Mice fibroblast cells (FLS) treated with 5 ng/mL recombinant human TNF (R&D Systems) for 16 hours were harvested at 95% confluence ...
-
bioRxiv - Neuroscience 2022Quote: ... the media was supplemented with 40 ng/ml 3,3’,5-triiodothronine (T3, R&D systems). The spheroids were maintained in spheroid media from day 70 until completion of the experiment with half-media changes every other day ...
-
bioRxiv - Cell Biology 2021Quote: ... Medium was changed to differentiation medium supplemented with 5 ng/ml VEGF (R&D Systems) and 5 µmol/L XAV (Stemgent) ...
-
bioRxiv - Cell Biology 2021Quote: ... medium was changed to differentiation medium supplemented with 5 ng/ml VEGF (R&D Systems). After Day 8 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Media was changed to differentiation media supplemented with 5 ng/ml VEGF (R&D Systems) and 5 µmol/L XAV (Stemgent) ...
-
bioRxiv - Developmental Biology 2021Quote: ... media was changed to differentiation media supplemented with 5 ng/ml VEGF (R&D Systems). After day 8 ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 5% heat-inactivated fetal bovine serum (FBS) (R&D Systems, Minneapolis, MN, USA) and 5% Fetalgro® (Rocky Mountain Biologics ...
-
bioRxiv - Immunology 2022Quote: ... neutralising anti-IFNγ or isotype control (mouse IgG2b, both 5 μg/mL, R&D Systems) were added to cultures ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...